Company / EPS (Diluted)
Bio-Rad Laboratories EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$21.82
FY2025
5-year range
-$21.82 / $140.83
FY2021-FY2025
Trend
-262.2%
vs FY2024
Sector context
#157 of 159
Health Care
What the data says
EPS (Diluted) changed -262% YoY in FY2025, a notable deviation from the 9-year average annual change of +74%.
Based on SEC 10-K filings.
-21.82 in FY2025.
Declined from $140.83 to $-21.82 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 159This company -$21.82 Sector average $1.67
▼
-1408.0% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 262.2% year-over-year.
- Ranks #157 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2023.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$21.82 | -262.2% |
| FY2024 | $13.45 | -90.4% |
| FY2023 | $140.83 | +11.4% |
| FY2022 | $126.47 | +117.0% |
| FY2021 | $58.27 | +381.6% |
| FY2020 | $12.10 | +197.3% |
| FY2019 | $4.07 | +362.5% |
| FY2018 | $0.88 | -76.3% |
| FY2017 | $3.71 | +21.6% |
| FY2016 | $3.05 | +13.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026